218 related articles for article (PubMed ID: 34626090)
21. Hemodynamic heterogeneity of connective tissue disease patients with borderline mean pulmonary artery pressure and its distinctive characters from those with normal pulmonary artery pressure: a retrospective study.
Asari Y; Yamasaki Y; Tsuchida K; Suzuki K; Akashi YJ; Okazaki T; Ozaki S; Yamada H; Kawahata K
Clin Rheumatol; 2018 Dec; 37(12):3373-3380. PubMed ID: 29777409
[TBL] [Abstract][Full Text] [Related]
22. Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy.
Abston E; Hon S; Lawrence R; Berman J; Govender P; Farber HW
Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):234-238. PubMed ID: 33093789
[TBL] [Abstract][Full Text] [Related]
23. Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation.
LaRue SJ; Garcia-Cortes R; Nassif ME; Vader JM; Ray S; Ravichandran A; Rasalingham R; Silvestry SC; Ewald GA; Wang IW; Schilling JD
Cardiovasc Ther; 2015 Apr; 33(2):50-5. PubMed ID: 25759010
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask!
Sanges S; Sobanski V; Lamblin N; Hachulla E; Savale L; Montani D; Launay D
Rev Med Interne; 2024 Jan; 45(1):26-40. PubMed ID: 37925256
[TBL] [Abstract][Full Text] [Related]
25. Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience.
Sitbon O; Vonk Noordegraaf A
Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28096285
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.
Rajaram S; Swift AJ; Capener D; Elliot CA; Condliffe R; Davies C; Hill C; Hurdman J; Kidling R; Akil M; Wild JM; Kiely DG
J Rheumatol; 2012 Jun; 39(6):1265-74. PubMed ID: 22589263
[TBL] [Abstract][Full Text] [Related]
27. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
Coghlan JG; Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; Kuwana M; McLaughlin VV; Peacock AJ; Simonneau G; Vachiéry JL; Blair C; Gillies H; Miller KL; Harris JHN; Langley J; Rubin LJ;
Ann Rheum Dis; 2017 Jul; 76(7):1219-1227. PubMed ID: 28039187
[TBL] [Abstract][Full Text] [Related]
28. [Pulmonary artery hypertension associated with connective tissue diseases].
Sanchez O; Sitbon O; Garcia G; Jaïs X; Simonneau G; Humbert M
Presse Med; 2003 May; 32(17):789-99. PubMed ID: 12856325
[TBL] [Abstract][Full Text] [Related]
29. [Update in pulmonary hypertension associated with connective tissue diseases - a systematic literature review].
Tamborrini G; Distler O
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S199-202. PubMed ID: 18814096
[TBL] [Abstract][Full Text] [Related]
30. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
Choi JH; Joo SJ; Kim J
Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
[TBL] [Abstract][Full Text] [Related]
31. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
[TBL] [Abstract][Full Text] [Related]
32. Predictors of exercise-induced pulmonary hypertension in patients with connective tissue disease.
Miyanaga S; Kubota K; Iwatani N; Higo K; Miyata M; Horizoe Y; Ojima S; Kawasoe S; Kubozono T; Ohishi M
Heart Vessels; 2019 Sep; 34(9):1509-1518. PubMed ID: 30904986
[TBL] [Abstract][Full Text] [Related]
33. Right-heart function related to the results of acute pulmonary vasodilator testing in patients with pulmonary arterial hypertension caused by connective tissue disease.
Liu YT; Li MT; Fang Q; Tian Z; Guo XX; Zhu WL; Wang Q; Zeng XF
J Am Soc Echocardiogr; 2012 Mar; 25(3):274-9. PubMed ID: 22137255
[TBL] [Abstract][Full Text] [Related]
34. Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study.
Frantz RP; Durst L; Burger CD; Oudiz RJ; Bourge RC; Franco V; Waxman AB; McDevitt S; Walker S
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):550-7. PubMed ID: 24742768
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
37. Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure.
El Midany AA; Mostafa EA; Azab S; Hassan GA
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):963-8. PubMed ID: 23985411
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary vasodilators can lead to various complications in pulmonary "arterial" hypertension associated with congenital heart disease.
Chida-Nagai A; Sagawa K; Tsujioka T; Fujimoto T; Taniguchi K; Sasaki O; Izumi G; Yamazawa H; Masaki N; Manabe A; Takeda A
Heart Vessels; 2020 Sep; 35(9):1307-1315. PubMed ID: 32285188
[TBL] [Abstract][Full Text] [Related]
39. Use of β-Blockers in Pulmonary Hypertension.
Perros F; de Man FS; Bogaard HJ; Antigny F; Simonneau G; Bonnet S; Provencher S; Galiè N; Humbert M
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364092
[TBL] [Abstract][Full Text] [Related]
40. Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization.
Kovacs G; Maier R; Aberer E; Brodmann M; Scheidl S; Hesse C; Troester N; Salmhofer W; Stauber R; Fuerst FC; Thonhofer R; Ofner-Kopeinig P; Gruenig E; Olschewski H
Chest; 2010 Aug; 138(2):270-8. PubMed ID: 20418368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
